Short description
EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.
Description
EvolveImmune Therapeutics develops an immunobiological platform that delivers both sustained immune activation and tumor cell targeting in a single agent. Through integrated signaling, EVs first in category biologics directly target tumor cells and provide potent, tissue-localized amplification of cytokine secretion at the tumor site to maximize tumor killing.
The company's biotherapeutics are engineered to overcome the limitations of conventional CD3 bispecific and other immune therapies to offer a better future for our patients in need, by maximizing therapeutic benefit and minimizing toxicity.
Total funding
$$2020202
Sign in for full access
Location
Branford, Connecticut, United States, North America
Founded on
January 1, 2020
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccessforu, Uh Ohhhh, Nopepepe, Cannot Access, Noway Youcantaccess
Sign in for full access
Founders
Charles Fuchs, Sidi Chen, Stephen Bloch